| Entry |
|
| Name |
Motixafortide (USAN/INN) |
| Formula |
C97H144FN33O19S2
|
| Exact mass |
2158.0742
|
| Mol weight |
2159.52
|
| Structure |
 |
| Remark |
| Product (DG03214): | D12282<US> |
|
| Efficacy |
Antineoplastic |
| Type |
Modified peptide |
| Target |
|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AX Other immunostimulants
L03AX23 Motixafortide
D12281 Motixafortide (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Chemokine receptors
CXCR4 (CD184)
D12281 Motixafortide (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|